Summary
Johnson & Johnson (JNJ) filed an 8-K on July 21, 2021, primarily to announce its second-quarter financial results for the period ending July 4, 2021. The filing includes a press release and supplementary sales data, providing investors with key performance metrics for the quarter. This information is crucial for understanding the company's operational performance and financial health in the most recent reporting period, allowing for comparisons to previous periods and analyst expectations.
Key Highlights
- 1JNJ announced its second-quarter 2021 financial results on July 21, 2021.
- 2The report covers the financial performance for the quarter ended July 4, 2021.
- 3The filing includes a press release detailing sales and earnings for the period.
- 4Unaudited comparative supplementary sales data and condensed consolidated statements of earnings are provided.
- 5This 8-K serves as the official disclosure of the company's Q2 2021 financial outcomes.
Frequently Asked Questions
The main purpose of this 8-K filing is to publicly disclose Johnson & Johnson's financial results for the second quarter of 2021, which ended on July 4, 2021. It includes a press release and supplementary financial data.
The detailed financial information, including sales and earnings for the second quarter of 2021, is provided in the press release (Exhibit 99.1) and the unaudited comparative supplementary sales data and condensed consolidated statement of earnings (Exhibit 99.2) attached to this 8-K filing.
The financial data in this filing covers the second quarter of Johnson & Johnson's fiscal year 2021, which concluded on July 4, 2021.